New Gene Therapies Have Hit The Market; Drug Makers Discuss Initial Launch Trends

 
• By Jessica Merrill

BioMarin, Sarepta and bluebird bio are all launching new gene therapies in the US. The drug makers updated investors on the commercial execution during second quarter financial earnings calls.

• Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies